Rhythm Biosciences Limited (FRA:0RY)
0.0680
+0.0055 (8.80%)
At close: Jan 9, 2026
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of €23.4 million as of January 12, 2026. Its market cap has increased by 61.34% in one year.
Market Cap
23.40M
Enterprise Value
23.19M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.07
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 20.89M to 23.40M, an increase of 12.01%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 23.40M | -6.43% |
| Dec 31, 2025 | 25.01M | 69.56% |
| Dec 31, 2024 | 14.75M | -19.89% |
| Dec 29, 2023 | 18.41M | -86.53% |
| Dec 30, 2022 | 136.73M | -33.97% |
| Dec 31, 2021 | 207.06M | 86.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |